Annual Current Liabilities
$4.62 M
-$17.50 M-79.12%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual total current liabilities is $4.62 million, with the most recent change of -$17.50 million (-79.12%) on December 31, 2023.
- During the last 3 years, AVTX annual current liabilities has fallen by -$10.61 million (-69.67%).
- AVTX annual current liabilities is now -82.39% below its all-time high of $26.22 million, reached on December 31, 2018.
Performance
AVTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$60.67 M
-$35.72 M-37.06%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly total current liabilities is $60.67 million, with the most recent change of -$35.72 million (-37.06%) on September 30, 2024.
- Over the past year, AVTX quarterly current liabilities has dropped by -$35.72 million (-37.06%).
- AVTX quarterly current liabilities is now -71.87% below its all-time high of $215.70 million, reached on March 31, 2024.
Performance
AVTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AVTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.1% | -37.1% |
| 3 y3 years | -69.7% | +174.4% |
| 5 y5 years | -82.4% | +251.5% |
AVTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.1% | at low | -71.9% | +1213.9% |
| 5 y | 5-year | -79.1% | at low | -71.9% | +1213.9% |
| alltime | all time | -82.4% | +50.6% | -71.9% | +3550.2% |
Avalo Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $60.67 M(-37.1%) |
| Jun 2024 | - | $96.40 M(-55.3%) |
| Mar 2024 | - | $215.70 M(+4570.9%) |
| Dec 2023 | $4.62 M(-79.1%) | $4.62 M(-23.1%) |
| Sep 2023 | - | $6.00 M(-73.3%) |
| Jun 2023 | - | $22.45 M(-3.4%) |
| Mar 2023 | - | $23.25 M(+5.1%) |
| Dec 2022 | $22.11 M(+11.2%) | $22.11 M(+21.8%) |
| Sep 2022 | - | $18.15 M(+17.9%) |
| Jun 2022 | - | $15.39 M(-14.0%) |
| Mar 2022 | - | $17.89 M(-10.0%) |
| Dec 2021 | $19.89 M(+30.6%) | $19.89 M(+4.5%) |
| Sep 2021 | - | $19.04 M(-12.2%) |
| Jun 2021 | - | $21.67 M(-17.8%) |
| Mar 2021 | - | $26.36 M(+73.1%) |
| Dec 2020 | $15.22 M(+25.2%) | $15.22 M(-8.1%) |
| Sep 2020 | - | $16.57 M(+13.5%) |
| Jun 2020 | - | $14.60 M(-4.8%) |
| Mar 2020 | - | $15.33 M(+26.1%) |
| Dec 2019 | $12.16 M | $12.16 M(-29.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $17.26 M(-8.0%) |
| Jun 2019 | - | $18.77 M(-33.3%) |
| Mar 2019 | - | $28.13 M(+7.3%) |
| Dec 2018 | $26.22 M(+136.4%) | $26.22 M(+5.2%) |
| Sep 2018 | - | $24.91 M(+30.8%) |
| Jun 2018 | - | $19.05 M(+28.8%) |
| Mar 2018 | - | $14.79 M(+33.4%) |
| Dec 2017 | $11.09 M(+157.2%) | $11.09 M(+129.4%) |
| Sep 2017 | - | $4.83 M(+190.8%) |
| Jun 2017 | - | $1.66 M(-39.3%) |
| Mar 2017 | - | $2.74 M(-36.5%) |
| Dec 2016 | $4.31 M(-26.3%) | $4.31 M(-42.5%) |
| Sep 2016 | - | $7.50 M(+13.8%) |
| Jun 2016 | - | $6.59 M(+6.7%) |
| Mar 2016 | - | $6.17 M(+5.5%) |
| Dec 2015 | $5.85 M(+17.1%) | $5.85 M(-12.1%) |
| Sep 2015 | - | $6.65 M(+14.5%) |
| Jun 2015 | - | $5.81 M(+1.1%) |
| Mar 2015 | - | $5.75 M(+15.2%) |
| Dec 2014 | $4.99 M(+62.9%) | $4.99 M |
| Dec 2013 | $3.07 M | - |
FAQ
- What is Avalo Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Avalo Therapeutics?
- What is Avalo Therapeutics annual current liabilities year-on-year change?
- What is Avalo Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly current liabilities year-on-year change?
What is Avalo Therapeutics annual total current liabilities?
The current annual current liabilities of AVTX is $4.62 M
What is the all time high annual current liabilities for Avalo Therapeutics?
Avalo Therapeutics all-time high annual total current liabilities is $26.22 M
What is Avalo Therapeutics annual current liabilities year-on-year change?
Over the past year, AVTX annual total current liabilities has changed by -$17.50 M (-79.12%)
What is Avalo Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of AVTX is $60.67 M
What is the all time high quarterly current liabilities for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly total current liabilities is $215.70 M
What is Avalo Therapeutics quarterly current liabilities year-on-year change?
Over the past year, AVTX quarterly total current liabilities has changed by -$35.72 M (-37.06%)